Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Dysregulation of the Immune Response in Coronavirus Disease 2019 Publisher Pubmed



Mohamed Khosroshahi L1 ; Rezaei N1, 2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  3. 3. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Cell Biology International Published:2021


Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can trigger a cytokine storm in the pulmonary tissue by releasing various types of mediators, leading to acute respiratory distress syndrome (ARDS). Increased neutrophil-to-lymphocyte ratio, as well as CD4+ T lymphopenia, is reported in cases with novel coronavirus disease (COVID-19), meanwhile, lymphopenia is a significant finding in the majority of COVID-19 cases with a severe phenotype. Moreover, excessive activation of monocyte/macrophage and cytokine storms are associated with the severity of the disease and the related complications in SARS-CoV-2 infection. Understanding the immune response dysregulation in COVID-19 is essential to develop more effective diagnostic, therapeutic, and prophylactic strategies in this pandemic. © 2020 International Federation for Cell Biology
Related Docs
View other Related Docs
1. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)
2. How Covid-19 Has Globalized: Unknown Origin, Rapid Transmission, and the Immune System Nourishment, Advances in Experimental Medicine and Biology (2021)
3. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)
4. Computed Tomography Scan in Covid-19: A Systematic Review and Meta-Analysis, Polish Journal of Radiology (2022)
5. Altered Immunoemotional Regulatory System in Covid-19: From the Origins to Opportunities, Journal of Neuroimmunology (2021)
6. Risk Factors for Adverse Outcomes of Covid-19 Patients: Possible Basis for Diverse Responses to the Novel Coronavirus Sars-Cov-2, Life Sciences (2021)
7. The Immune System and Covid-19: Friend or Foe?, Life Sciences (2020)
8. The Immune System As a Target for Therapy of Sars-Cov-2: A Systematic Review of the Current Immunotherapies for Covid-19, Life Sciences (2020)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (84)
Mohammadreza Salehi (12)
Other Related Docs
9. Immunosenescence and Inflamm-Ageing in Covid-19, Ageing Research Reviews (2023)
10. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
11. A Systematic Review of Pregnant Women With Covid-19 and Their Neonates, Archives of Gynecology and Obstetrics (2021)
12. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
13. Exploration of the Epidemiological and Emotional Impact of Quarantine and Isolation During the Covid-19 Pandemic, Advances in Experimental Medicine and Biology (2021)
14. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
15. Computational Drug Discovery and Repurposing for the Treatment of Covid-19: A Systematic Review, Bioorganic Chemistry (2021)
16. Pathological Effects of Sars-Cov-2 on Hematological and Immunological Cells: Alterations in Count, Morphology, and Function, Pathology Research and Practice (2022)
17. How Prevalent Is Cancer in Confirmed Cases With Coronaviruses and Severe Acute Respiratory Syndromes?, Advances in Experimental Medicine and Biology (2021)
18. Prevention of Covid-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions, Advances in Experimental Medicine and Biology (2021)
19. Sars-Cov-2: A Comprehensive Review From Pathogenicity of the Virus to Clinical Consequences, Journal of Medical Virology (2020)
20. Clinical and Laboratory Predictors of Severity, Criticality, and Mortality in Covid-19: A Multisystem Disease, Advances in Experimental Medicine and Biology (2021)
21. Health Care Policies and Covid-19 Prevalence: Is There Any Association?, International Journal of Health Services (2022)
22. Human Coronaviruses Sars-Cov, Mers-Cov, and Sars-Cov-2 in Children, Journal of Pediatric Nursing (2021)
23. Interferon Therapy in Patients With Sars, Mers, and Covid-19: A Systematic Review and Meta-Analysis of Clinical Studies, European Journal of Pharmacology (2021)
24. Health and Art (Heart): Integrating Science and Art to Fight Covid-19, Advances in Experimental Medicine and Biology (2021)
25. Microfluidic Devices for Detection of Rna Viruses, Reviews in Medical Virology (2021)
26. Coronavirus: Pure Infectious Disease or Genetic Predisposition, Advances in Experimental Medicine and Biology (2021)
27. Neurologic Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
28. Interdisciplinary Approaches to Covid-19, Advances in Experimental Medicine and Biology (2021)
29. The Contributory Role of Lymphocyte Subsets, Pathophysiology of Lymphopenia and Its Implication As Prognostic and Therapeutic Opportunity in Covid-19, International Immunopharmacology (2021)
30. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the Sars-Cov-2 Cytokine Storm, Current Pharmaceutical Design (2021)
31. Biosensing Surfaces and Therapeutic Biomaterials for the Central Nervous System in Covid-19, Emergent Materials (2021)
32. Clinical Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
33. Lymphopenia in Covid-19: Therapeutic Opportunities, Cell Biology International (2020)
34. Covid-19 in Patients With Cancer, Advances in Experimental Medicine and Biology (2021)
35. Cytokines and Covid-19: Friends or Foes?, Human Vaccines and Immunotherapeutics (2020)
36. Dynamic Antibody Response: A Biomarker for Covid-19, Clinical Laboratory (2021)
37. The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations During the Covid-19 Pandemic, Biomolecules (2021)
38. Covid-19: Transmission, Prevention, and Potential Therapeutic Opportunities, Clinica Chimica Acta (2020)
39. Regenerative Medicine in Covid-19 Treatment: Real Opportunities and Range of Promises, Stem Cell Reviews and Reports (2021)
40. Angiotensin-Converting Enzyme 2 (Ace2) Receptor and Sars-Cov-2: Potential Therapeutic Targeting, European Journal of Pharmacology (2020)
41. Nutrition and Immunity in Covid-19, Advances in Experimental Medicine and Biology (2021)
42. Serological Tests for Covid-19: Potential Opportunities, Cell Biology International (2021)
43. Covid-19 and Multiorgan Failure: A Narrative Review on Potential Mechanisms, Journal of Molecular Histology (2020)
44. A Borderless Solution Is Needed for a Borderless Complexity, Like Covid-19, the Universal Invader, Advances in Experimental Medicine and Biology (2021)
45. Advances in Immunotherapy for Covid-19: A Comprehensive Review, International Immunopharmacology (2021)
46. The Chimera of S1 and N Proteins of Sars-Cov-2: Can It Be a Potential Vaccine Candidate for Covid-19?, Expert Review of Vaccines (2022)
47. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
48. Covid-19 and Its Global Economic Impact, Advances in Experimental Medicine and Biology (2021)
49. Primary Immunodeficiency Diseases in Covid-19 Pandemic: A Predisposing or Protective Factor?, American Journal of the Medical Sciences (2020)
50. Immune-Based Therapy for Covid-19, Advances in Experimental Medicine and Biology (2021)